Funded Tech Companies
iOnctura
Headquartered in Genève, iOnctura is venture-backed, with investment from Syncona, VI Partners and 3B Future Health Fund.
Company Overview
Company Name
iOnctura
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Campus Biotech Innovation Park Avenue Sécheron 15
Genève, 1202
CH
Genève, 1202
CH
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Founded in June 2017, iOnctura is a clinical stage biopharmaceutical company focused on delivering innovative cancer treatments to patients with unmet medical need. iOnctura is uncovering the key to unlock difficult to treat tumors burdened by stroma and immune mediated resistance. We do this by simultaneously targeting multiple tumor survival mechanisms with a single drug, disrupting the dynamic interplay at the heart of the tumor-stroma-immune interface.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/20/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Catherine Pickering
Chief Financial Officer
David SEEBERGER
Chief Marketing Officer
Michael LAHN
Chief Technical Officer
Lars Veen
Company Investors
- Syncona
- VI Partners
- 3B Future Health Fund
- INKEF Capital
- European Innovation Council Fund
- M Ventures
- Schroders Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs